BioStock: BrainCool’s new CEO on his visions for the company

BrainCool has strong momentum right now. Karolinska Institutet has initiated patient recruitment for a cardiac arrest study with the company’s device RhinoChill, and a recently completed rights issue was subscribed to a total of 171 per cent. BioStock contacted the new CEO Jon Berg for a status update and to learn more about his visions for the company.
– BrainCool is in an exciting phase and, we believe there is a great market potential and global demand for our cooling devices, says Berg.

Read the full interview with Jon Berg at biostock.se:

https://www.biostock.se/en/2024/06/braincools-new-ceo-on-his-visions-for-the-company/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/